Two large US investments in human vaccines for avian influenza A(H5N1) are aimed at boosting US readiness in the case of a pandemic.

Last week, the US Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority, announced it will pay Moderna…